906  0 Kommentare Novo Nordisk A/S - Status regarding Novo Nordisk's holding of its own shares

Bagsværd, Denmark, 2 January 2015 - In continuation of the company's announcements dated 30 January 2014 and 30 October 2014 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 31 December 2014 owned 56,807,153 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 11,361,431 or 2.1% of the total share capital.

In the fourth quarter of 2014 a total of 13,914,000 B shares were repurchased, and 383,136 B shares were disposed of to employees in connection with employee incentive programmes.